51. 全身性強皮症 Scleroderma Clinical trials / Disease details
臨床試験数 : 523 / 薬物数 : 608 - (DrugBank : 156) / 標的遺伝子数 : 114 - 標的パスウェイ数 : 215
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04927390 (ClinicalTrials.gov) | November 1, 2021 | 19/5/2021 | Mycophenolate in Limited Cutaneous Systemic Sclerosis (MINIMISE-Pilot) | A Randomised Prospective Open Label Pilot Trial Comparing Mycophenolate Mofetil (MMF) With no Immunosuppression in Adults With Limited Cutaneous Systemic Sclerosis | Systemic Sclerosis;Limited Cutaneous Systemic Sclerosis | Drug: Mycophenolate Mofetil 500mg | University College, London | Versus Arthritis | Not yet recruiting | 18 Years | N/A | All | 120 | Phase 2 | United Kingdom |